BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28634935)

  • 1. Generation of Induced Pluripotent Stem Cells in Defined Three-Dimensional Hydrogels.
    Caiazzo M; Tabata Y; Lutolf MP
    Methods Mol Biol; 2017; 1612():65-78. PubMed ID: 28634935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing well-defined photopolymerized synthetic matrices for three-dimensional culture and differentiation of induced pluripotent stem cells.
    Ovadia EM; Colby DW; Kloxin AM
    Biomater Sci; 2018 May; 6(6):1358-1370. PubMed ID: 29675520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stiffness of Hydrogels Regulates Cellular Reprogramming Efficiency Through Mesenchymal-to-Epithelial Transition and Stemness Markers.
    Choi B; Park KS; Kim JH; Ko KW; Kim JS; Han DK; Lee SH
    Macromol Biosci; 2016 Feb; 16(2):199-206. PubMed ID: 26439948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing Induced Pluripotent Stem Cell Generation by MicroRNA.
    Dang J; Rana TM
    Methods Mol Biol; 2016; 1357():71-84. PubMed ID: 25687299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Fibrinogen for Maintenance and Differentiation of Induced Pluripotent Stem Cells in Two Dimensions and Three Dimensions.
    Gandhi JK; Knudsen T; Hill M; Roy B; Bachman L; Pfannkoch-Andrews C; Schmidt KN; Metko MM; Ackerman MJ; Resch Z; Pulido JS; Marmorstein AD
    Stem Cells Transl Med; 2019 Jun; 8(6):512-521. PubMed ID: 30768863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced Pluripotent Stem Cells: Generation, Characterization, and Differentiation--Methods and Protocols.
    Graversen VK; Chavala SH
    Methods Mol Biol; 2016; 1357():395-401. PubMed ID: 25403469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Maturation of Induced Pluripotent Stem Cell Hepatocytes in Extracellular Matrix-A Comparative Analysis of Bioartificial Liver Microenvironments.
    Wang B; Jakus AE; Baptista PM; Soker S; Soto-Gutierrez A; Abecassis MM; Shah RN; Wertheim JA
    Stem Cells Transl Med; 2016 Sep; 5(9):1257-67. PubMed ID: 27421950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
    Heng BC; Fussenegger M
    Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of miRNA-212/132 improves the reprogramming of fibroblasts into induced pluripotent stem cells by de-repressing important epigenetic remodelling factors.
    Pfaff N; Liebhaber S; Möbus S; Beh-Pajooh A; Fiedler J; Pfanne A; Schambach A; Thum T; Cantz T; Moritz T
    Stem Cell Res; 2017 Apr; 20():70-75. PubMed ID: 28314201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Urinal Cell Reprogramming: Synthetic 3D Peptide Hydrogels Enhance Induced Pluripotent Stem Cell Population Homogeneity.
    Sun W; Zhang S; Zhou T; Shan Y; Gao F; Zhang Y; Zhang D; Xiong Y; Mai Y; Fan K; Davidson AJ; Pan G; Zhang X
    ACS Biomater Sci Eng; 2020 Nov; 6(11):6263-6275. PubMed ID: 33449655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Fetal Bovine Serum (FBS) on Efficacy of Cellular Reprogramming for Induced Pluripotent Stem Cell (iPSC) Generation.
    Kwon D; Kim JS; Cha BH; Park KS; Han I; Park KS; Bae H; Han MK; Kim KS; Lee SH
    Cell Transplant; 2016; 25(6):1025-42. PubMed ID: 26450367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human-Induced Pluripotent Stem Cell Culture Methods Under cGMP Conditions.
    Rivera T; Zhao Y; Ni Y; Wang J
    Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e117. PubMed ID: 32649060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A defined xeno-free and feeder-free culture system for the derivation, expansion and direct differentiation of transgene-free patient-specific induced pluripotent stem cells.
    Lu HF; Chai C; Lim TC; Leong MF; Lim JK; Gao S; Lim KL; Wan AC
    Biomaterials; 2014 Mar; 35(9):2816-26. PubMed ID: 24411336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of iPS Cells from Granulosa Cells.
    Mao J; Liu L
    Methods Mol Biol; 2016; 1357():451-64. PubMed ID: 25403467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A highly optimized protocol for reprogramming cancer cells to pluripotency using nonviral plasmid vectors.
    Zhao H; Davies TJ; Ning J; Chang Y; Sachamitr P; Sattler S; Fairchild PJ; Huang FP
    Cell Reprogram; 2015 Feb; 17(1):7-18. PubMed ID: 25549177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using microRNAs to enhance the generation of induced pluripotent stem cells.
    Li Z; Rana TM
    Curr Protoc Stem Cell Biol; 2012; Chapter 4():Unit 4A.4. PubMed ID: 22415842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generating iPSCs: translating cell reprogramming science into scalable and robust biomanufacturing strategies.
    Silva M; Daheron L; Hurley H; Bure K; Barker R; Carr AJ; Williams D; Kim HW; French A; Coffey PJ; Cooper-White JJ; Reeve B; Rao M; Snyder EY; Ng KS; Mead BE; Smith JA; Karp JM; Brindley DA; Wall I
    Cell Stem Cell; 2015 Jan; 16(1):13-7. PubMed ID: 25575079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of Reprogramming Intermediates During Generation of Induced Pluripotent Stem Cells from Mouse Embryonic Fibroblasts.
    Nefzger CM; Alaei S; Polo JM
    Methods Mol Biol; 2015; 1330():205-18. PubMed ID: 26621600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Pluripotent Stem Cells (iPSC) Generation, Culture, and Differentiation to Lung Progenitor Cells.
    Ghaedi M; Niklason LE
    Methods Mol Biol; 2019; 1576():55-92. PubMed ID: 27628133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.